Relief Therapeutics Holding SA (RLFTY)
OTCMKTS
· Delayed Price · Currency is USD
3.010
+0.030 (1.01%)
At close: Jul 3, 2025
Relief Therapeutics Holding Employees
Relief Therapeutics Holding had 31 employees as of December 31, 2024. The number of employees decreased by 18 or -36.73% compared to the previous year.
Employees
31
Change (1Y)
-18
Growth (1Y)
-36.73%
Revenue / Employee
$299,627
Profits / Employee
-$609,400
Market Cap
34.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Relief Therapeutics Holding News
- 16 days ago - Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 - Accesswire
- 24 days ago - Relief Therapeutics Announces Results of Annual General Meeting - Accesswire
- 6 weeks ago - Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 - Accesswire
- 7 weeks ago - Relief Therapeutics Publishes 2025 Annual General Meeting Agenda - Accesswire
- 3 months ago - Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B - Seeking Alpha
- 3 months ago - Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update - Accesswire
- 4 months ago - Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion - Accesswire
- 5 months ago - Relief Therapeutics to get European patent for investigational drug RLF‑TD011 - Seeking Alpha